A Double-Blind, Placebo-Controlled Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HM15136 in Obese or Overweight Subjects with Co-morbidities
J Endocr Soc
; 6(Suppl 1):A409, 2022.
Article
in English
| PubMed Central | ID: covidwho-2119819
Full text:
Available
Collection:
Databases of international organizations
Database:
PubMed Central
Type of study:
Cohort study
/
Experimental Studies
/
Observational study
/
Prognostic study
/
Randomized controlled trials
Language:
English
Journal:
J Endocr Soc
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS